List of Excipients in API orlistat
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing orlistat
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Haleon US Holdings LLC | ALLI | orlistat | 0135-0461 | CELLULOSE, MICROCRYSTALLINE | |
| Haleon US Holdings LLC | ALLI | orlistat | 0135-0461 | FD&C BLUE NO. 2 | |
| Haleon US Holdings LLC | ALLI | orlistat | 0135-0461 | FERROUS OXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for orlistat
Excipient focus: AMMONIA
orlistat drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
orlistat drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
orlistat drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
orlistat drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROUS OXIDE
orlistat drug variants containing FERROUS OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing FERROUS OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
orlistat drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
orlistat drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
orlistat drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
orlistat drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
orlistat drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
orlistat drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
orlistat drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
orlistat drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| Aphena Pharma Solutions - Tennessee LLC | orlistat | 71610-805 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
orlistat drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
orlistat drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | orlistat | 0135-0461 |
| H2-Pharma LLC | orlistat | 61269-460 |
| H2-Pharma LLC | orlistat | 61269-565 |
| >Company | >Ingredient | >NDC |
orlistat drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
